Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Reghin – page 2

138 clinical trials in Reghin, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Reghin at a glance
138
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

138 trials in Reghin

Open in trial search

Study of Elafibranor for Adults with Primary Biliary Cholangitis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC

Neutropenia

Recruiting

Study on Mavorixafor for Patients with Chronic Neutropenia Experiencing Recurrent or Serious Infections

Investigational
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Mavorixafor
  • Sponsor:X4 Pharmaceuticals Inc.

Cardiac failure

Recruiting

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Efficacy and safety of weekly subcutaneous zenagamtide versus placebo in adults with type 2 diabetes not controlled by diet and exercise

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

A Phase 3 Study of Once‑Daily Treprostinil Palmitil Inhalation Powder for Adults with Pulmonary Arterial Hypertension

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil Palmitil
  • Sponsor:Insmed Inc.

Efficacy and safety of osilodrostat with drug combination in patients with hypertension caused by Cushing's syndrome

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Recordati AG

Embolism venous

Recruiting

Safety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:RBD4059
  • Sponsor:Ribocure Pharmaceuticals AB

Efficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Votoplam
  • Sponsor:Novartis Pharma AG

Pharmacokinetics and safety of subcutaneous vs intravenous human normal immunoglobulin in adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Human Normal Immunoglobulin
  • Sponsor:Grifols Therapeutics LLC

Long‑Term Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil Palmitil
  • Sponsor:Insmed Inc.

Obesity+1

Recruiting

A study of eloralintide in adults with persistent obesity or overweight who are currently treated with a weekly incretin medication

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 sodium
  • Sponsor:Eli Lilly & Co.

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Reghin

What the registry says about research in the country

01 Immune System Diseases and Dermatology

In Reghin, clinical trial activity includes research in immune system diseases with a strong focus on moderate to severe plaque psoriasis. These studies are designed to evaluate the long-term safety and treatment performance of new and existing therapies, helping clarify how well they support disease control in everyday care.

  • Moderate to severe plaque psoriasis
  • Long-term treatment safety
  • Comparison of therapeutic effectiveness

This area reflects ongoing efforts to improve care options for chronic inflammatory skin disease while monitoring overall treatment safety.

02 Nutritional and Metabolic Diseases

Another active research area in Reghin is nutritional and metabolic diseases, especially studies involving type 2 diabetes and overweight or obesity. The trials are focused on testing whether new therapies can better lower blood sugar, reduce body weight, and improve metabolic control.

  • Type 2 diabetes
  • Overweight or obesity
  • Blood sugar control
  • Weight management

These studies aim to support better treatment strategies for people living with common, long-term metabolic conditions.

03 Diabetes and Cardiometabolic Research

Clinical trials in this category are examining treatments for type 2 diabetes in people who need improved glycaemic control. The research is centered on whether newer options can offer stronger effects on HbA1c and overall cardiometabolic health compared with established therapies.

  • Type 2 diabetes
  • HbA1c improvement
  • Metabolic treatment effectiveness

This work supports the search for more effective ways to manage diabetes in routine clinical practice.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.